FDA rejection
Scope
Date
~
-
Artificial intelligence
S.Korea rejects patent claims for AI-invented products
South Korea’s intellectual property office has rejected patent applications that claimed an artificial intelligence system as their inventor, ...
Oct 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Cryptocurrencies
Terra founder Do Kwon vows to communicate proactively with press
Terraform Labs' founder and CEO Do Kwon has reemerged on Twitter, after making his account private for a couple of days. Two weeks after Terra&...
Jun 10, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Medytox-Hugel dispute over botox strain intensifies with ITC probe
A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...
May 03, 2022 (Gmt+09:00)
-
Bio & Pharma
FutureChem seeks FDA nod for prostate cancer radiopharma trials
FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...
Apr 20, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Beauty & Cosmetics
LG Household’s China strategy put to test as shares crash
LG Household & Health Care Ltd.’s shares have been flying high since its market debut in 2001, and have more recently basked in the global...
Jan 10, 2022 (Gmt+09:00)
language -
COVID-19
Celltrion wins COVID-19 treatment approval from Europe
South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...
Nov 15, 2021 (Gmt+09:00)
language -
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Hahn & Co. sues Namyang owner over completion of $267 mn deal
South Korea’s private equity firm Hahn & Co. filed a lawsuit against the owner of Namyang Dairy Products and his family to complete a $267...
Aug 30, 2021 (Gmt+09:00)
-
Batteries
SK reiterates rejection of LG’s hefty demand for battery dispute settlement
SK Innovation Co. again refused to accept LG Energy Solution Ltd.’s demand that SK pay a hefty amount of compensation for its involvement in a...
Mar 26, 2021 (Gmt+09:00)
-
Shareholder activism
Proxy advisers ISS, Glass Lewis urge LG shareholders to reject spin-off plan
Proxy advisers Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co. have urged shareholders of LG Corp. to vote against the South...
Mar 15, 2021 (Gmt+09:00)
-
Airlines
Asiana deal botched as HDC rejects creditors’ latest offer
HDC Hyundai Development Co.’s planned takeover of Asiana Airlines Inc. has fallen through as the preferred buyer renewed its request for further...
Sep 03, 2020 (Gmt+09:00)
-
Robotics
Korea's first neurosurgery robot to debut; to seek FDA approval
Koh Young Technology Inc., a 3D inspection device maker in South Korea, has commercialized a neurosurgical robotics system for the second time in the ...
Jun 22, 2020 (Gmt+09:00)
-
NPS rejects $177 mn debt for Carlyle’s refinancing of ADT Korea
The National Pension Service’s (NPS) rejection last week of 200 billion won ($177 million) investment in ADT Korea, owned by the Carlyle Group, has ca...
Mar 01, 2017 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet